Nevertheless, the mechanism that regulates PD-L1 expression in tumor cells has not been fully elucidated, understanding of which regulatory network would aid to develop potential therapeutic strategies to enhance efficacy of anti-tumor immunotherapy. The gene discussed is CD274; the disease is neoplasm.